5.00
0.00 (0.00%)
| Penutupan Terdahulu | 5.00 |
| Buka | 5.03 |
| Jumlah Dagangan | 11,071 |
| Purata Dagangan (3B) | 648,815 |
| Modal Pasaran | 295,483,168 |
| Harga / Pendapatan (P/E Ke hadapan) | 103.09 |
| Harga / Jualan (P/S) | 1.49 |
| Harga / Buku (P/B) | 0.680 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 29 Oct 2025 |
| Margin Keuntungan | -21.98% |
| Margin Operasi (TTM) | -81.99% |
| EPS Cair (TTM) | -0.760 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 5.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 2.30% |
| Nisbah Semasa (MRQ) | 3.92 |
| Aliran Tunai Operasi (OCF TTM) | -56.47 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -41.71 M |
| Pulangan Atas Aset (ROA TTM) | -7.05% |
| Pulangan Atas Ekuiti (ROE TTM) | -8.39% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Vanda Pharmaceuticals Inc. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 4.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | 4.0 |
| Purata | 1.75 |
|
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 7.16% |
| % Dimiliki oleh Institusi | 78.96% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Krensavage Asset Management, Llc | 30 Sep 2025 | 1,180,388 |
| Empire Financial Management Company, Llc | 30 Sep 2025 | 758,091 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 20.00 (HC Wainwright & Co., 300.00%) | Beli |
| Median | 11.00 (120.00%) | |
| Rendah | 11.00 (Cantor Fitzgerald, 120.00%) | Beli |
| 11.00 (B. Riley Securities, 120.00%) | Beli | |
| Purata | 14.00 (180.00%) | |
| Jumlah | 3 Beli | |
| Harga Purata @ Panggilan | 4.63 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 19 Nov 2025 | 20.00 (300.00%) | Beli | 5.14 |
| B. Riley Securities | 05 Nov 2025 | 11.00 (120.00%) | Beli | 4.44 |
| Cantor Fitzgerald | 30 Oct 2025 | 11.00 (120.00%) | Beli | 4.32 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |